Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

Clinical trial NCT00270049 · COMPLETED

Trial details

NCT number: NCT00270049
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia Leukemia, Lymphocytic, Chronic Leukemia, Lymphocytic Cancer Neoplasms Quality of Life

Start date: 1990-11-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.